✦ LIBER ✦

Nuclear roundness factor and local failure from definitive radiation therapy for prostatic carcinoma

✍ Scribed by James Shaeffer; James A. Tegeler; Anas M. El-Mahdi

Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 115 KB
Volume: 19
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(90)90899-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nuclear roundness factor and local failu

Nuclear roundness factor and local failure from definitive radiation therapy for prostatic carcinoma

✍ James Shaeffer; James A. Tegeler; Deborah A. Kuban; Christine B. Philput; Anas M 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 735 KB

Nuclear morphometry predicts disease-fre

Nuclear morphometry predicts disease-free interval for clinically localized adenocarcinoma of the prostate treated with definitive radiation therapy

✍ Mark D. Hurwitz; Theodore L. DeWeese; Eva S. Zinreich; Jonathan I. Epstein; Alan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 2 views

Men treated for prostate cancer often have unexpected outcomes despite predictive models based on stage, grade and prostate-specific antigen (PSA). Previous results have indicated that nuclear morphometry can predict patient outcome in urologic malignancies. Application of this analytical method in

Influence of body mass index on prostate

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

✍ Jason A. Efstathiou; Ming-Hui Chen; Andrew A. Renshaw; Marian J. Loffredo; Antho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio

Long-term hormone therapy and radiation

Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma

✍ Andre Konski; Deborah Watkins-Bruner; Harmar Brereton; Steven Feigenberg; Gerald 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

Comments on “technical and tumor-related

Comments on “technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate”

✍ Richard E. Peschel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Advanced age at diagnosis is an independ

Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma

✍ Anthony V. D'Amico; Kerri Cote; Marian Loffredo; Andrew A. Renshaw; Ming-Hui Che 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract ## BACKGROUND Whether age at diagnosis is predictive of time to prostate carcinoma specific death after external beam radiation therapy (RT) for patients who are diagnosed with clinically localized prostate carcinoma during the prostate specific antigen (PSA) era has not been investiga